LGALS3 and cerebrovascular disorder: In the past decade, GAL3 has been found to be dysregulated or considered as a biomarker in various diseases including cardiac [45, 46], renal [45, 47], hepatic [48], cerebrovascular diseases [49], and many types of cancer [45, 50].